4 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow REP 3123: new trials by email Literature Review of REP 3123 trials Research Report on REP 3123
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Potential Impact of a High-fat Meal on the Pharmacokinetics of CRS3123 in Healthy Adult Participants CRS3123 200 mg capsule - Food Effect in Healthy Participants | Phase 1 | Completed | Crestone, Inc | 17 | 2025-04-21 | 2026-03-18 |
| Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection CRS3123, Active Comparator - Clostridioides Difficile Infection | Phase 2 | Completed | Crestone, Inc | 43 | 2021-01-05 | 2026-03-27 |
| Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123. Placebo, CRS3123 - Clostridium Difficile Infection | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 36 | 2014-06-01 | 2016-06-13 |
| Phase I Trial of a Single Dose of CRS3123 CRS3123, Placebo - Clostridium Difficile Colitis | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 40 | 2012-05-22 | 2017-09-25 |
Clostridium Infections (2) · Enterocolitis, Pseudomembranous (1)
Crestone, Inc (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2)
United States (4) · Canada (1)
Urs Ochsner, PhD (1)